 NRx Pharmaceuticals Inc NASDAQ: NRXP has filed a counterclaim against its former partner, Relief Therapeutics Holdings OTC: RLFTF, in an ongoing dispute over the COVID-19 treatment Zyesami avaptadil. NRx alleges that Relief has breached a collaboration agreement and falsely asserted worldwide right to Zyesami. 